Table of Contents
Volume 1 | Issue 3
Publication Date: February 2000- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
169 |
Lung Cancer in the New Millennium Chandra P. Belani |
|
Researches in Brief | ||
175-176 |
1999 European Cancer Conference CIG Media Group |
|
177-178 |
Paclitaxel 175 mg/m2 plus Carboplatin versus Paclitaxel 225 mg/m2 plus Carboplatin for Advanced Non–Small-Cell Lung Cancer (NSCLC) CIG Media Group |
|
Comprehensive Review | ||
181-190 |
Small-Cell Lung Cancer at the Millennium: Radiotherapy Innovations Improve Survival While New Chemotherapy Treatments Remain Unproven Nevin Murray |
|
Commentary | ||
192-193 |
Commentary on “Small-Cell Lung Cancer at the Millennium: Radiotherapy Innovations” James A. Bonner |
|
Comprehensive Review | ||
194-200 |
Multimodality Treatment of Resectable Non–Small-Cell Lung Cancer Robert J. Ginsberg |
|
Commentary | ||
201 |
Commentary on “Multimodality Treatment of Resectable Non–Small-Cell Lung Cancer” Jack A. Roth |
|
Original Contribution | ||
202-207 |
Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group Study Pasquale Comella, Nicola Panza, Luigi Manzione, Giuseppe De Cataldis, Riccardo Cioffi, Luigi Maiorino, Vito Lorusso, Alfredo Lamberti, Enrico Micillo, Michele Natale, Domenico Bilancia, Gianpaolo Nicolella, Angelo Di Nota, Sergio Mancarella, Giuseppe Frasci, Giuseppe Comella, on behalf of the Southern Italy Cooperative Oncology Group* |
|
Commentary | ||
208 |
Commentary on “Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer (NSCLC)” Gregory A. Masters |
|
Original Contribution | ||
211-215 |
Clinical Characteristics and the Impact of Surgery and Chemotherapy on Survival of Patients With Advanced and Metastatic Bronchioloalveolar Carcinoma: A Retrospective Study Remco Donker, David J. Stewart, Simone Dahrouge, William K. Evans, Farid M. Shamji, Donna E. Maziak, Eva M. Tomiak |
|
Commentary | ||
216 |
Commentary on “Clinical Characteristics and the Impact of Surgery and Chemotherapy on Survival of Patients With Advanced and Metastatic Bronchioloalveolar Carcinoma: A Retrospective Study” Nico van Zandwijk |
|
Translational Medicine | ||
218-226 |
Gene Therapy for Lung Cancer Paul J. Mosca, Michael A. Morse, Thomas A. D’Amico, Jeffrey Crawford, H. Kim Lyerly |
|
Current Trials | ||
227-229 |
Phase I Study of Recombinant Carcinoembryonic Antigen (CEA) Vaccinia Virus Vaccine With Post Vaccination Carcinoembryonic Antigen Peptide (CAP-1) Boost David J. Cole, Paul L. Baron, Paul O’Brien, Carolyn E. Reed, Jeffrey Schlom, Kwon Y. Tsang |
|
Brief Communication | ||
230-233 |
Anatomic Lung Resections Using Minimally Invasive Thoracic Surgery (MITS)* Robert L. Quigley |
|
Letter to the Editor | ||
234 |
letter to the editor Eric Vallières |
|